feed,title,long_url,short_url
Benzinga,Vigil Neuroscience Touts Positive Healthy Volunteer Data From Lead Program In Rare Neurological Disease,https://benzinga.com/general/biotech/22/11/29525052/vigil-neuroscience-touts-positive-healthy-volunteer-data-from-lead-program-in-rare-neurological-d,https://bit.ly/3DtnOFb
Benzinga,Sonnet BioTherapeutics Highlights Safety Profile For Lead Cancer Candidate,https://benzinga.com/general/biotech/22/11/29524835/sonnet-biotherapeutics-highlights-safety-profile-for-lead-cancer-candidate,https://bit.ly/3zyBXjp
